74 related articles for article (PubMed ID: 8136201)
1. [Evidence for the existence of L-dopa-immunoreactive neurons in the human mesencephalic region].
Komori K; Nakamura M; Yamaoka H; Kunimi Y; Yamaoka K; Fujita K; Naitoh H; Karasawa N; Kuroda M; Ito T
No To Shinkei; 1994 Jan; 46(1):53-7. PubMed ID: 8136201
[TBL] [Abstract][Full Text] [Related]
2. Identification of L-dopa immunoreactivity in some neurons in the human mesencephalic region: a novel dopa neuron group?
Komori K; Uesaka S; Yamaoka H; Fujita K; Yamaoka K; Naitoh H; Kuroda M; Karasawa N; Ito T; Kasahara Y
Neurosci Lett; 1993 Jul; 157(1):13-6. PubMed ID: 8233022
[TBL] [Abstract][Full Text] [Related]
3. Identification of L-dopa-dopamine and L-dopa cell bodies in the rat mesencephalic dopaminergic cell systems.
Mons N; Tison F; Geffard M
Synapse; 1989; 4(2):99-105. PubMed ID: 2781469
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization of L-dopa and dopamine in the brain of the chicken (Gallus domesticus).
Moons L; van Gils J; Ghijsels E; Vandesande F
J Comp Neurol; 1994 Aug; 346(1):97-118. PubMed ID: 7962714
[TBL] [Abstract][Full Text] [Related]
5. Endogenous L-dopa, its immunoreactivity in neurons of midbrain and its projection fields in the cat.
Kitahama K; Mons N; Okamura H; Jouvet M; Geffard M
Neurosci Lett; 1988 Dec; 95(1-3):47-52. PubMed ID: 3226622
[TBL] [Abstract][Full Text] [Related]
6. Aromatic L-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla.
Kitahama K; Ikemoto K; Jouvet A; Araneda S; Nagatsu I; Raynaud B; Nishimura A; Nishi K; Niwa S
J Chem Neuroanat; 2009 Oct; 38(2):130-40. PubMed ID: 19589383
[TBL] [Abstract][Full Text] [Related]
7. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.
Kitahama K; Geffard M; Araneda S; Arai R; Ogawa K; Nagatsu I; Pequignot JM
Brain Res; 2007 Sep; 1167():56-70. PubMed ID: 17692830
[TBL] [Abstract][Full Text] [Related]
8. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
10. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
11. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
[TBL] [Abstract][Full Text] [Related]
13. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.
Azam L; Winzer-Serhan UH; Chen Y; Leslie FM
J Comp Neurol; 2002 Mar; 444(3):260-74. PubMed ID: 11840479
[TBL] [Abstract][Full Text] [Related]
14. Dopamine synthesis, uptake and metabolism in embryonic rat mesencephalic cultures.
Schinelli S; Paolillo M; Quartieri M; Santagostino G
Pharmacol Res; 1993; 28(3):265-76. PubMed ID: 8108317
[TBL] [Abstract][Full Text] [Related]
15. First trimester development of the human nigrostriatal dopamine system.
Almqvist PM; Akesson E; Wahlberg LU; Pschera H; Seiger A; Sundstrom E
Exp Neurol; 1996 Jun; 139(2):227-37. PubMed ID: 8654525
[TBL] [Abstract][Full Text] [Related]
16. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
[TBL] [Abstract][Full Text] [Related]
17. Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes.
Kokkinou I; Nikolouzou E; Hatzimanolis A; Fragoulis EG; Vassilacopoulou D
Blood Cells Mol Dis; 2009; 42(1):92-8. PubMed ID: 19041269
[TBL] [Abstract][Full Text] [Related]
18. Uptake and decarboxylation of L-3,4-dihydroxyphenylalanine in cultured monkey placenta amniotic epithelial cells.
Elwan MA; Sakuragawa N
Placenta; 2007; 28(2-3):245-8. PubMed ID: 16580727
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of cocaine on firing rate and pattern of dopamine neurons: role of alpha1 receptors and comparison with L-dopa and apomorphine.
Zhou Y; Bunney BS; Shi WX
J Pharmacol Exp Ther; 2006 Apr; 317(1):196-201. PubMed ID: 16330495
[TBL] [Abstract][Full Text] [Related]
20. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG
Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
